Chondroitin-4-Sulfate
General | Antibody | Glycoprotein | Glycolipid | Enzyme | Reference4 antibodies registered for EP0082
Name | 2H6 |
---|---|
Species | Mouse |
Category | Monoclonal |
Isotype | IgM |
Immunogen | chondroitin sulfate proteoglycans purified from 10-day-old rat brain[2] |
Recognition region | -{GlcA(b1-3)[HSO3(-4)]GalNAc(b1-4)}n- |
Immunoprecipitation | |
Immunoblot | [2] |
ELISA/RIA | |
Flow cytometry | |
Histochemistry | [3] |
Availability | COSMO BIO Co.Ltd. |
Application | |
Comment | |
Name | BE-123 |
Species | Mouse |
Category | Monoclonal |
Isotype | IgG1 |
Immunogen | |
Recognition region | -{GlcA(b1-3)[HSO3(-4)]GalNAc(b1-4)}n- |
Immunoprecipitation | |
Immunoblot | |
ELISA/RIA | |
Flow cytometry | |
Histochemistry | |
Availability | Millipore AbD Serotec LifeSpan Biosciences,Inc. Abnova Affinity BioReagents Acris Antibodies GmbH MP Biomedicals,LLC GenWay Biotech Inc. |
Application | |
Comment | |
Name | CS-56 |
Species | Mouse |
Category | Monoclonal |
Isotype | IgM |
Immunogen | ventral membranes of chicken gizzard fibroblasts[16] |
Recognition region | -{GlcA(b1-3)[HSO3(-4)]GalNAc(b1-4)}n- -{GlcA(b1-3)[HSO3(-6)]GalNAc(b1-4)}n- |
Immunoprecipitation | |
Immunoblot | [5][6][7*][8] |
ELISA/RIA | |
Flow cytometry | |
Histochemistry | [9] |
Availability | SEIKAGAKU BIOBUSINESS CORPORATION -English SEIKAGAKU BIOBUSINESS CORPORATION -Japanese Santa Cruz Biotechnology, Inc. abcam Sigma-Aldrich AbD Serotec Abnova Affinity BioReagents GENETEX,Inc. GenWay Biotech Inc. LifeSpan Biosciences,Inc. Novus Biologicals, LLC Acris Antibodies GmbH |
Application | |
Comment | |
Name | LY111 |
Species | Mouse |
Category | Monoclonal |
Isotype | IgM |
Immunogen | type IX collagen (HMW collagen) prepared from chick embryonic cartilage[15] |
Recognition region | -{GlcA(b1-3)[HSO3(-4)]GalNAc(b1-4)}n- |
Immunoprecipitation | |
Immunoblot | [4*] |
ELISA/RIA | |
Flow cytometry | |
Histochemistry | |
Availability | SEIKAGAKU BIOBUSINESS CORPORATION -English SEIKAGAKU BIOBUSINESS CORPORATION -Japanese |
Application | |
Comment | |